Literature DB >> 3207364

Myasthenia gravis: discontinuation of long-term azathioprine.

M Michels, R Hohlfeld, H P Hartung, K Heininger, U A Besinger, K V Toyka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3207364     DOI： 10.1002/ana.410240619

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  4 in total

1.  Myasthenic crisis after the cessation of FK506 in a patient with myasthenia gravis.

Authors:  Tetsuro Konishi; Mitsuru Sanada; Kazuya Takehana
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

Review 2.  Myasthenia gravis as a prototype autoimmune receptor disease.

Authors:  A C Hoedemaekers; P J van Breda Vriesman; M H De Baets
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

3.  Long term treatment of myasthenia gravis with azathioprine.

Authors:  V Fonseca; C W Havard
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

Review 4.  Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.

Authors:  Nico Melzer; Tobias Ruck; Peter Fuhr; Ralf Gold; Reinhard Hohlfeld; Alexander Marx; Arthur Melms; Björn Tackenberg; Berthold Schalke; Christiane Schneider-Gold; Fritz Zimprich; Sven G Meuth; Heinz Wiendl
Journal:  J Neurol       Date:  2016-02-17       Impact factor: 4.849
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.